Use of bacterial phage associated lysing enzymes for...

Details Use of bacterial phage associated lysing enzymes for... Use of bacterial phage associated lysing enzymes for...

2006-11-28

2006-11-28

Prats, Francisco (Department: 1651)

Drug, bio-affecting and body treating compositions

Enzyme or coenzyme containing

C424S093600, C435S195000, C435S183000

Reexamination Certificate

active

07141241

ABSTRACT:
The present invention relates to an oral delivery system containing a bacteriophage associated lysin enzyme for the treatment of [Streptococcus pneumoniaeand]Hemophilus influenzaesinus
asal infections.

REFERENCES:
patent: 2019789 (1935-11-01), Mahannah
patent: 2315260 (1943-03-01), Lancaster
patent: 2763931 (1956-09-01), McMillan
patent: 3465445 (1969-09-01), Fisher
patent: 3622677 (1971-11-01), Short et al.
patent: 3852424 (1974-12-01), Gaeumann et al.
patent: 3929994 (1975-12-01), Hirsch et al.
patent: 3983209 (1976-09-01), Schmitt
patent: 4062941 (1977-12-01), Davies
patent: 4115546 (1978-09-01), Vidra et al.
patent: 4116327 (1978-09-01), Eglinton et al.
patent: 4122158 (1978-10-01), Schmitt
patent: 4313734 (1982-02-01), Leuvering
patent: 4355022 (1982-10-01), Rabussay
patent: 4361537 (1982-11-01), Deutsch et al.
patent: 4369308 (1983-01-01), Trubiano
patent: 4459361 (1984-07-01), Gefter
patent: 4497900 (1985-02-01), Abram et al.
patent: 4521252 (1985-06-01), Miyake et al.
patent: 4552839 (1985-11-01), Gould et al.
patent: 4707543 (1987-11-01), Zollinger et al.
patent: 4713249 (1987-12-01), Schroder
patent: 4742981 (1988-05-01), Converse
patent: 4784948 (1988-11-01), Scott et al.
patent: 4812445 (1989-03-01), Eden et al.
patent: 4847199 (1989-07-01), Snyder et al.
patent: 4885163 (1989-12-01), Shaar et al.
patent: 4933185 (1990-06-01), Wheatley et al.
patent: 4948726 (1990-08-01), Longoria
patent: 4957686 (1990-09-01), Norris
patent: 5079174 (1992-01-01), Buck et al.
patent: 5108758 (1992-04-01), Allwood et al.
patent: 5120643 (1992-06-01), Ching et al.
patent: 5162226 (1992-11-01), Beachey et al.
patent: 5260292 (1993-11-01), Robinson et al.
patent: 5294369 (1994-03-01), Shigekawa et al.
patent: 5352588 (1994-10-01), Fischetti et al.
patent: 5360617 (1994-11-01), Gasson
patent: 5372931 (1994-12-01), Friedman et al.
patent: 5384265 (1995-01-01), Kidwell et al.
patent: 5393658 (1995-02-01), Olsen
patent: 5479732 (1996-01-01), Burtch et al.
patent: 5500350 (1996-03-01), Baker et al.
patent: 5514602 (1996-05-01), Brooks, Jr. et al.
patent: 5556944 (1996-09-01), Fischetti et al.
patent: 5571667 (1996-11-01), Chu et al.
patent: 5587288 (1996-12-01), Cheung et al.
patent: 5602040 (1997-02-01), May et al.
patent: 5604109 (1997-02-01), Fischetti et al.
patent: 5604110 (1997-02-01), Baker et al.
patent: 5605793 (1997-02-01), Stemmer
patent: 5616686 (1997-04-01), Fischetti et al.
patent: 5643767 (1997-07-01), Fischetti et al.
patent: 5688501 (1997-11-01), Merril et al.
patent: 5707822 (1998-01-01), Fischetti et al.
patent: 5723303 (1998-03-01), Fischetti et al.
patent: 5741487 (1998-04-01), Asai et al.
patent: 5760026 (1998-06-01), Blackburn et al.
patent: 5763251 (1998-06-01), Gasson
patent: 5786205 (1998-07-01), Fischetti et al.
patent: 5821088 (1998-10-01), Darzins et al.
patent: 5842314 (1998-12-01), Porter
patent: 5882631 (1999-03-01), Suga et al.
patent: 5910441 (1999-06-01), Rocha et al.
patent: 5968763 (1999-10-01), Fischetti et al.
patent: 5976792 (1999-11-01), Cheung et al.
patent: 5985271 (1999-11-01), Fischetti et al.
patent: 5985654 (1999-11-01), Fischetti et al.
patent: 5997862 (1999-12-01), Fischetti et al.
patent: 6017528 (2000-01-01), Fischetti et al.
patent: 6056954 (2000-05-01), Fischetti et al.
patent: 6056955 (2000-05-01), Fischetti et al.
patent: 6083684 (2000-07-01), Gasson
patent: 6113887 (2000-09-01), Mori et al.
patent: 6132970 (2000-10-01), Stemmer
patent: 6159688 (2000-12-01), Borchert et al.
patent: 6177554 (2001-01-01), Woo et al.
patent: 6187757 (2001-02-01), Clackson et al.
patent: 6190659 (2001-02-01), Pancholi et al.
patent: 6238661 (2001-05-01), Fischetti et al.
patent: 6248324 (2001-06-01), Fischetti et al.
patent: 6254866 (2001-07-01), Fischetti et al.
patent: 6264945 (2001-07-01), Fischetti et al.
patent: 6277399 (2001-08-01), Fischetti et al.
patent: 6326002 (2001-12-01), Fischetti et al.
patent: 6331405 (2001-12-01), Rambukkana et al.
patent: 6335012 (2002-01-01), Fischetti et al.
patent: 6355477 (2002-03-01), Fischetti et al.
patent: 0293249 (1988-11-01), None
patent: 0359873 (1990-03-01), None
patent: 0 510 907 (1992-10-01), None
patent: 0510907 A 2 (1992-10-01), None
patent: 587541 (1994-03-01), None
patent: 0646646 (1995-04-01), None
patent: 2357246 (1978-02-01), None
patent: WO-9323544 (1993-11-01), None
patent: WO-9531562 (1995-11-01), None
patent: WO 96 07329 (1996-03-01), None
patent: WO-9607329 (1996-03-01), None
patent: WO 97 02351 (1997-01-01), None
patent: WO-9702351 (1997-01-01), None
patent: WO 99 04809 (1999-02-01), None
patent: WO-9904809 (1999-02-01), None
patent: WO 03/024410 (2003-03-01), None
KH Nasibulini et al; RU-2103991; Composition for treatingStreptococcaldiseases—comprises purified concentrate ofStreptococcalbacteriophage, solution of quinsosol, dry lanolin, albumin and vegetable oil; XP-002141110.
LD Demidova et al; RU2064299; Cattle mastitis therapeutic preparation—comprises lyso: amidase of specific lytic activity and mono- and di-basic sodium phosphate(s); XP-002141111.
Babenko et al. Enzymatic lysis ofStaphylococciin relation to their species and strain properties, 1990. Database Medline Online, US National Library of Medicine, Bethesda, MD. US, Database Accession No. 90297672 XP002170795, abstract only.
Bartell, et al., Origin of polysaccharide depolymerase associated with bacteriophage infection, Journal of Virology, Mar. 1969, pp. 290-296, vol. 3, No. 3.
Behnke, et al., Cloning and expression inEscherichia coli, Bacillus subtilisandStreptococcus sanguisof a gene for staphylokinase—a bacterial plasminogen activator, Mol Gen Genet, Dec. 1987, pp. 528-534, vol. 210.
Bessen, et al., Chemical characterization of binding properties of opacity-associated protein II from Neisseria gonorrheae, Infection and Immunity, Jan. 1987, pp. 141-147, vol. 55, No. 1.
Biziulevichius, et al., In vivo studies on lysosubtilin: 3. Efficacy for treatment of mastitis and superficial lesions of the udder and teats in cows, 1998, Database Biosis Online, Biosciences Information Service, Philadelphia, PA, US, Database Accession No. PREV199800492606, XP002183274, abstract only.
Boizet, et al., Cloning, expression and sequence analysis of an endolysin-encoding gene ofLactobacillus bulgaricusbacteriophage mv1, Gene, 2000, pp. 61-67, vol. 94.
Caldwell, et al., Purification and partial characterization of the major outer membrane protein ofChlamydia trachomatis, Infection and Immunity, Mar. 1981, pp. 1161-1176, vol. 31, No. 3.
Young et al. Phages will out: strategies of host cell lysis, Trends in Microbiology, vol. 8 No. 3, Mar. 2000, pp. 120-127.
Corbel, et al., Soluble antigens obtained from influenza virus by treatment with non-ionic detergent, J Hyg.,Camb., 1970, pp. 81-96, vol. 68.
Croux, et al., Interchange of functional domains switches enzymes specificity: construction of a chimeric pneumococcal-clostridial cell wall lytic enzyme, Molecular Microbiology, 1993, pp. 1019-1025, vol. 9, No. 5.
Diaz, et al., Chimeric phage-bacterial enzymes: a clue to the modular evolution of genes, Proc. Natl. Acad. Sci. USA, Oct. 1990, pp. 8125-8129, vol. 87.
Diaz, et al., Chimeric pneumococcal cell wall lytic enzymes reveal important physiological and evolutionary traits, Journal of Biological Chemistry, Mar. 25, 1991, pp. 5464-5471, vol. 266, No. 9.
Dixon, et al., Lysostaphin: an enzymatic approach toStphylococcaldisease. III. Combined lysostaphin-methicillin therapy of establishedStaphylococcalabcesses in mice, The Yale Journal of Biology and Medicine, Aug. 1968, pp. 62-68, vol. 41, No. 1.
Fischetti, et al., Size variation of the M protein in group Astreptococci, Journal of Exp. Med., Jun. 1, 1985, pp. 1384-1401, vol. 161, No. 6.
Garcia, et al., Bacteriophages ofStreptococcus pneumoniae: A molecular approach, Microbial Drug Resistance. Summer 1997, pp. 165-176, vol. 3, No. 2.
Garcia, et al., Cloning, purification and biochemical characterization of the pneumococcal bacteriophage Cp-1 lysin, Journal of Virology, Aug. 1987, pp. 2573-2580, vol. 61, No. 8.
Garcia, et al., Modular organization of the lytic enzymes ofStreptococcus pneumo

Affiliated with

Also associated with

Rating

Use of bacterial phage associated lysing enzymes for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of bacterial phage associated lysing enzymes for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of bacterial phage associated lysing enzymes for... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3704643